Skip to content
10-Q

Quarterly Report

EVELO BIOSCIENCES, INC.

0001694665-23-000182

← back to feed
Filed
Nov 9, 2023 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2023 · Nov 6, 2023 18.93M sh
Shares Diluted Q3 2023 · Sep 30, 2023 17.38M sh
Shares Diluted Q3 2023 · Sep 30, 2023 9.55M sh
Shares Diluted restated Q3 2023 · Sep 30, 2022 5.4M sh
Shares Diluted restated Q3 2023 · Sep 30, 2022 3.98M sh
Capex Q3 2023 · Sep 30, 2023 $59K
Capex Q3 2023 · Sep 30, 2022 $394K
Operating Cash Flow Q3 2023 · Sep 30, 2023 −$50.51M
Operating Cash Flow Q3 2023 · Sep 30, 2022 −$78.05M
Long Term Debt Q3 2023 · Sep 30, 2023 $0
Long Term Debt Q3 2023 · Dec 31, 2022 $43.61M
Short Term Debt Q3 2023 · Sep 30, 2023 $33.95M
Short Term Debt Q3 2023 · Dec 31, 2022 $0
Cash And Equivalents Q3 2023 · Sep 30, 2023 $17.26M
Cash And Equivalents Q3 2023 · Dec 31, 2022 $47.94M
Cash And Equivalents Q3 2023 · Sep 30, 2022 $69.05M
Stockholders Equity Q3 2023 · Sep 30, 2023 −$26.71M
Stockholders Equity Q3 2023 · Jun 30, 2023 −$46.13M
Stockholders Equity Q3 2023 · Mar 31, 2023 −$27.39M
Stockholders Equity Q3 2023 · Dec 31, 2022 −$4.99M
Stockholders Equity Q3 2023 · Sep 30, 2022 $9.33M
Stockholders Equity Q3 2023 · Jun 30, 2022 $35.65M
Stockholders Equity Q3 2023 · Mar 31, 2022 −$16.8M
Stockholders Equity Q3 2023 · Dec 31, 2021 $8.67M
Current Liabilities Q3 2023 · Sep 30, 2023 $39.76M
Current Liabilities Q3 2023 · Dec 31, 2022 $12.4M
Total Liabilities Q3 2023 · Sep 30, 2023 $47.33M
Total Liabilities Q3 2023 · Dec 31, 2022 $69.43M
Current Assets Q3 2023 · Sep 30, 2023 $18.94M
Current Assets Q3 2023 · Dec 31, 2022 $51.57M
Total Assets Q3 2023 · Sep 30, 2023 $20.63M
Total Assets Q3 2023 · Dec 31, 2022 $64.44M
Eps Diluted Q3 2023 · Sep 30, 2023 −$0.71
Eps Diluted Q3 2023 · Sep 30, 2023 −$6.16
Eps Diluted restated Q3 2023 · Sep 30, 2022 −$5.66
Eps Diluted restated Q3 2023 · Sep 30, 2022 −$22.88
Eps Basic Q3 2023 · Sep 30, 2023 −$0.71
Eps Basic Q3 2023 · Sep 30, 2023 −$6.16
Eps Basic restated Q3 2023 · Sep 30, 2022 −$5.66
Eps Basic restated Q3 2023 · Sep 30, 2022 −$22.88
Sga Expense Q3 2023 · Sep 30, 2023 $3.89M
Sga Expense Q3 2023 · Sep 30, 2023 $15.85M
Sga Expense Q3 2023 · Sep 30, 2022 $7.13M
Sga Expense Q3 2023 · Sep 30, 2022 $24.91M
Rd Expense Q3 2023 · Sep 30, 2023 $6.5M
Rd Expense Q3 2023 · Sep 30, 2023 $37.4M
Rd Expense Q3 2023 · Sep 30, 2022 $21.93M
Rd Expense Q3 2023 · Sep 30, 2022 $62.47M
Net Income Q3 2023 · Sep 30, 2023 −$12.36M
Net Income Q3 2023 · Sep 30, 2023 −$58.81M
Net Income Q3 2023 · Jun 30, 2023 −$21.1M
Net Income Q3 2023 · Mar 31, 2023 −$25.34M
Net Income Q3 2023 · Sep 30, 2022 −$30.56M
Net Income Q3 2023 · Sep 30, 2022 −$90.99M
Net Income Q3 2023 · Jun 30, 2022 −$30.56M
Net Income Q3 2023 · Mar 31, 2022 −$29.86M
Operating Income Q3 2023 · Sep 30, 2023 −$11.18M
Operating Income Q3 2023 · Sep 30, 2023 −$55.66M
Operating Income Q3 2023 · Sep 30, 2022 −$29.05M
Operating Income Q3 2023 · Sep 30, 2022 −$87.38M